| scholarly article | Q13442814 |
| P50 | author | Arthur E. Frankel | Q62695282 |
| P2093 | author name string | K Hansen | |
| A Thorburn | |||
| J Thorburn | |||
| H Horita | |||
| J Redzic | |||
| P2860 | cites work | p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy | Q24312147 |
| Inhibition of macroautophagy triggers apoptosis | Q24338482 | ||
| LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| Growth factor regulation of autophagy and cell survival in the absence of apoptosis | Q28588809 | ||
| Autophagy: process and function | Q29547296 | ||
| How to interpret LC3 immunoblotting | Q29614175 | ||
| Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3 | Q29614176 | ||
| Autophagy in cell death: an innocent convict? | Q29617604 | ||
| Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis | Q29617725 | ||
| Self-eating and self-killing: crosstalk between autophagy and apoptosis | Q29617748 | ||
| Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy | Q29619961 | ||
| Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8 | Q29620200 | ||
| Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes | Q29620366 | ||
| Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma | Q29622918 | ||
| Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion | Q33193752 | ||
| Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. | Q34324018 | ||
| Another way to die: autophagic programmed cell death | Q34462605 | ||
| Induction of apoptosis by tumor cell-targeted toxins | Q35636355 | ||
| The role of autophagy in cancer development and response to therapy. | Q36251939 | ||
| Autophagy in cancer: good, bad, or both? | Q36612549 | ||
| The CASBAH: a searchable database of caspase substrates | Q36726238 | ||
| The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy | Q36990578 | ||
| Apoptosis and autophagy: regulatory connections between two supposedly different processes | Q36996255 | ||
| The roles of therapy-induced autophagy and necrosis in cancer treatment | Q37038235 | ||
| Immunological aspects of cancer chemotherapy | Q37039588 | ||
| Role and regulation of prolyl hydroxylase domain proteins | Q37079729 | ||
| Does autophagy have a license to kill mammalian cells? | Q37206999 | ||
| Autophagy plays a protective role during zVAD-induced necrotic cell death. | Q40016128 | ||
| HMGB1 is an endogenous immune adjuvant released by necrotic cells | Q40104101 | ||
| The extracellular release of HMGB1 during apoptotic cell death | Q40253423 | ||
| Elongation factor-2 kinase regulates autophagy in human glioblastoma cells | Q40304166 | ||
| Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude mice. | Q40465347 | ||
| A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells | Q40654233 | ||
| Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila | Q41913649 | ||
| Macroautophagy-dependent, intralysosomal cleavage of a betaine homocysteine methyltransferase fusion protein requires stable multimerization | Q42819738 | ||
| The immune response against dying tumor cells: avoid disaster, achieve cure | Q43681135 | ||
| Rapamycin pre-treatment protects against apoptosis | Q45300160 | ||
| Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. | Q45303665 | ||
| GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. | Q50681145 | ||
| Immunotoxin therapy of cancer | Q56454451 | ||
| P433 | issue | 1 | |
| P921 | main subject | autophagy | Q288322 |
| P304 | page(s) | 175-183 | |
| P577 | publication date | 2008-10-10 | |
| P1433 | published in | Cell Death & Differentiation | Q2943974 |
| P1476 | title | Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. | |
| P478 | volume | 16 |
| Q23757242 | A comprehensive glossary of autophagy-related molecules and processes (2nd edition) |
| Q38795278 | Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy |
| Q33392660 | Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms |
| Q35927584 | Antigen Cross-Priming of Cell-Associated Proteins is Enhanced by Macroautophagy within the Antigen Donor Cell. |
| Q35128650 | Apoptosis, autophagy, necroptosis, and cancer metastasis |
| Q48387954 | Autophagy Biomarkers Beclin 1 and p62 are Increased in Cerebrospinal Fluid after Traumatic Brain Injury |
| Q38202871 | Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy. |
| Q41919600 | Autophagy Proteins in Phagocyte Endocytosis and Exocytosis |
| Q37784816 | Autophagy Shapes Inflammation |
| Q49388079 | Autophagy and Disease |
| Q60912923 | Autophagy and Its Role in Protein Secretion: Implications for Cancer Therapy |
| Q42571763 | Autophagy and apoptosis: what is the connection? |
| Q38588827 | Autophagy and autophagy-related proteins in the immune system |
| Q37967998 | Autophagy and cancer |
| Q82997243 | Autophagy and cancer therapy |
| Q33584607 | Autophagy and cancer therapy |
| Q35928336 | Autophagy and mechanisms of effective immunity |
| Q37640885 | Autophagy and metastasis: another double-edged sword |
| Q38164897 | Autophagy in inflammation, infection, neurodegeneration and cancer |
| Q38869705 | Autophagy proteins in antigen processing for presentation on MHC molecules |
| Q47301146 | Autophagy's secret life: secretion instead of degradation |
| Q28078649 | Autophagy-Dependent Secretion: Contribution to Tumor Progression |
| Q37701461 | Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors |
| Q92508479 | Autophagy-dependent secretion: mechanism, factors secreted, and disease implications |
| Q35172545 | Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2. |
| Q35146596 | Autophagy: cancer's friend or foe? |
| Q33703592 | Autophagy: cerebral home cooking |
| Q26994999 | Cell death and DAMPs in acute pancreatitis |
| Q47614555 | Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. |
| Q36297374 | Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation |
| Q26768480 | Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases |
| Q38267715 | Complexity of danger: the diverse nature of damage-associated molecular patterns. |
| Q34097823 | Concanavalin A/IFN-gamma triggers autophagy-related necrotic hepatocyte death through IRGM1-mediated lysosomal membrane disruption |
| Q42553556 | Consensus guidelines for the detection of immunogenic cell death |
| Q38928826 | DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing. |
| Q34160434 | DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown |
| Q38079689 | DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death |
| Q30499197 | DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity |
| Q38784860 | Deconvoluting the relationships between autophagy and metastasis for potential cancer therapy |
| Q28087485 | Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme |
| Q27014829 | Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials |
| Q36469716 | Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells |
| Q39556431 | Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines |
| Q34770544 | EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages |
| Q37262805 | EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins |
| Q38032609 | Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling |
| Q58861244 | Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock |
| Q35527165 | Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design. |
| Q28077408 | Enhanced Therapeutic Efficacy in Cancer Patients by Short-term Fasting: The Autophagy Connection |
| Q33701939 | GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death |
| Q45072959 | HDAC inhibitors enhance the immunotherapy response of melanoma cells |
| Q34622835 | HMGB1 in health and disease |
| Q28243671 | HMGB1 loves company |
| Q34154797 | HMGB1 release and redox regulates autophagy and apoptosis in cancer cells |
| Q55422081 | Hemidesmus indicus induces immunogenic death in human colorectal cancer cells. |
| Q35193976 | High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress |
| Q34129779 | High mobility group box 1 (HMGB1) phenotypic role revealed with stress |
| Q33638306 | High-mobility group box 1 and cancer |
| Q28079816 | Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet |
| Q33639097 | Immunogenic and tolerogenic cell death |
| Q34311701 | Immunogenic cell death and DAMPs in cancer therapy |
| Q39178654 | Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer? |
| Q38255959 | Immunogenicity of necrotic cell death. |
| Q39429511 | Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer |
| Q55073227 | Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease. |
| Q35658529 | Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer |
| Q38622286 | Inflammatory Signaling Cascades and Autophagy in Cancer |
| Q37570542 | Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease |
| Q37437339 | Intralesional rose bengal in melanoma elicits tumor immunity via activation of dendritic cells by the release of high mobility group box 1 |
| Q36562901 | Life after death: targeting high mobility group box 1 in emergent cancer therapies |
| Q57498214 | Linking Autophagy and the Dysregulated NFκB/ SNAIL/YY1/RKIP/PTEN Loop in Cancer: Therapeutic Implications |
| Q59133970 | Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response |
| Q26822491 | Local tumour ablative therapies: opportunities for maximising immune engagement and activation |
| Q57269850 | Mechanism and medical implications of mammalian autophagy |
| Q92875471 | Mechanisms and Pathophysiological Roles of the ATG8 Conjugation Machinery |
| Q38786090 | Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1. |
| Q35919064 | MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy. |
| Q39490156 | Modulation of pediatric brain tumor autophagy and chemosensitivity |
| Q36301061 | Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death |
| Q84220622 | Molecular biology of chronic myeloid leukemia |
| Q33751106 | Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review |
| Q27023542 | Ménage à Trois in stress: DAMPs, redox and autophagy |
| Q35745292 | NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response |
| Q48591203 | Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance |
| Q41833885 | Non-apoptotic routes to defeat cancer |
| Q38726186 | Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant Cells |
| Q37707676 | Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity |
| Q21245758 | Oncolytic viruses as therapeutic cancer vaccines |
| Q27000955 | Oxidative stress-mediated HMGB1 biology |
| Q39223354 | Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter? |
| Q39381435 | Perpetual change: autophagy, the endothelium, and response to vascular injury |
| Q42370084 | Proinflammatory Effect of High Glucose Concentrations on HMrSV5 Cells via the Autocrine Effect of HMGB1 |
| Q39135022 | ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death |
| Q38696036 | Radiation-induced autophagy: mechanisms and consequences. |
| Q92676366 | Radiotherapy activates autophagy to increase CD8+ T cell infiltration by modulating major histocompatibility complex class-I expression in non-small cell lung cancer |
| Q38560502 | Redox distress and genetic defects conspire in systemic autoinflammatory diseases |
| Q100332692 | Regulation and Function of Autophagy During Ferroptosis |
| Q39903161 | Regulation of HMGB1 release by autophagy |
| Q35669880 | Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma |
| Q52629816 | Role of autophagy in IL-1β export and release from cells. |
| Q41922999 | Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cells |
| Q28246367 | Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells |
| Q98564735 | S100A8 transported by SEC23A inhibits metastatic colonization via autocrine activation of autophagy |
| Q28086767 | Secretory autophagy |
| Q38252589 | Secretory function of autophagy in innate immune cells |
| Q33809521 | Stepwise release of biologically active HMGB1 during HSV-2 infection |
| Q36747309 | Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response |
| Q37858077 | Targeting autophagy during cancer therapy to improve clinical outcomes |
| Q89587163 | The Multifaceted Effects of Autophagy on the Tumor Microenvironment |
| Q35393206 | The dynamic nature of autophagy in cancer |
| Q60924219 | The progression of HMGB1-induced autophagy in cancer biology |
| Q26829321 | The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases |
| Q38898214 | Transplantation and Damage-Associated Molecular Patterns (DAMPs). |
| Q37222171 | Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway |
| Q38622540 | [pemetrexed + sildenafil], via autophagy-dependent HDAC down-regulation, enhances the immunotherapy response of NSCLC cells |
| Q37475020 | miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma |
Search more.